Medi Caps Reports Significant Financial Declines, Indicating Operational Challenges Ahead
Medi Caps has reported its financial results for the quarter ending June 2025, revealing significant declines in key metrics. The company recorded negative figures in Profit Before Tax and Profit After Tax, alongside a contraction in net sales and a drop in operating profit, indicating challenges in operational efficiency.
Medi Caps, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results indicate a significant shift in the company's financial landscape, with notable declines across several key metrics.The Profit Before Tax less Other Income (PBT) for the quarter stands at Rs -3.82 crore, reflecting a substantial change compared to the average of the previous four quarters. Similarly, the Profit After Tax (PAT) has also shown a marked decline, recorded at Rs -3.49 crore, which is considerably lower than the prior averages.
Net sales for the latest six months reached Rs 9.66 crore, indicating a year-on-year contraction. The Operating Profit (PBDIT) has hit a low of Rs -3.37 crore, marking the lowest point in the last five quarters. Additionally, the Operating Profit Margin has fallen to 0.00%, suggesting a decline in operational efficiency. The Earnings per Share (EPS) has also reached a low of Rs -2.80, indicating reduced profitability for shareholders.
In light of these developments, Medi Caps has experienced an adjustment in its evaluation, reflecting the challenges faced in the recent quarter.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
